Biosimilar Education and Outreach

The contract focuses on the ongoing provision of comprehensive, data-driven education and outreach programs aimed at enhancing awareness and understanding of biosimilars among patients, healthcare providers, and other key stakeholders. It supports efforts to expand knowledge about the role and benefits of biosimilars, facilitating informed decision-making and acceptance in the medical community. This initiative is managed by the Food and Drug Administration (FDA) and falls under the NAICS code 561499, which generally corresponds to other business support services. Key contact points for the contract include a program liaison at the FDA accessible via a specified email, with the contracting officer yet to be designated. The contract is listed as a forecast opportunity with no specific solicitation number, allowing interested parties to prepare for future engagement. Although details regarding the exact performance location and organization type are unspecified, the overarching goal is to ensure effective communication and education around biosimilars on a broad scale, contributing to public health communication objectives.